{
    "title": "Amgen says Lumakras plus immunotherapy for lung cancer needs further study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11088949/Amgen-says-Lumakras-plus-immunotherapy-lung-cancer-needs-study.html",
    "date": "2022-08-07",
    "keywords": [
        "cancer",
        "study",
        "amgen",
        "drug",
        "lung",
        "combination",
        "toxicity",
        "dose",
        "treatment",
        "beasley",
        "immunotherapy",
        "trial",
        "immune",
        "system",
        "keytruda",
        "form",
        "disease",
        "year",
        "chemotherapy",
        "company",
        "presentation",
        "sunday",
        "world",
        "conference",
        "geneticmutation",
        "indication",
        "attack",
        "merck",
        "cos",
        "roche",
        "gene",
        "nonsmall",
        "cell",
        "food",
        "administration",
        "shrinkage",
        "duration",
        "response",
        "slamdunk",
        "success",
        "dr",
        "bob",
        "oncologist",
        "sloan",
        "center",
        "lead",
        "investigator",
        "forward",
        "iteration",
        "risk",
        "liver",
        "leadin",
        "tecentriq",
        "part",
        "time",
        "research",
        "development",
        "chief",
        "pdl1",
        "protein",
        "bodys",
        "reporting",
        "deena",
        "editing",
        "jan",
        "harvey"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}